Ted Ingemar Jakob Fjällman
Director/Board Member bij MENDUS AB
Profiel
Dr. Ted Ingemar Jakob Fjällman is an Independent Director at Mendus AB, a CEO at Flerie Invest AB and a Co-founder & Director at Tekiu Ltd.
He is on the Board of Directors at Mendus AB, Alder Therapeutics AB, Vitara Biomedical, Inc., XNK Therapeutics AB, Geneos Therapeutics, Inc., Synerkine Pharma BV, Amarna Therapeutics BV, Tekiu Ltd., CellProtect Nordic Pharmaceuticals AB, NorthX Biologics Matfors AB, Prokarium Holdings Ltd.
and Prokarium Ltd.
Dr. Fjällman was previously employed as a Board Member by Beactica AB, a Member of the Management Board by UK Research & Innovation, a Committee Member by The Bioindustry Association, a Project Manager by Royal Swedish Academy of Engineering Sciences, a Research & Teaching by University of Guelph, an Analyst by Sahlgrenska Universitetssjukhuset, and a Research Technician by New Zealand Pastoral Agriculture Research Institute Ltd.
He received his undergraduate degree from Waikato University, a graduate degree from the University of Gothenburg, a graduate degree from International Space University and a doctorate degree from the University of Guelph.
Actieve functies van Ted Ingemar Jakob Fjällman
Bedrijven | Functie | Begin |
---|---|---|
MENDUS AB | Director/Board Member | 13-12-2023 |
Prokarium Ltd.
Prokarium Ltd. Miscellaneous Commercial ServicesCommercial Services Prokarium Ltd. operates as a biopharmaceutical company that focuses on developing vaccination solutions based on synthetic biology. Its oral vaccine delivery platform Vaxonella stimulates broad protective immune responses applicable to a wide range of diseases. The company is headquartered in Keele, the United Kingdom. | Director/Board Member | 04-07-2014 |
Tekiu Ltd.
Tekiu Ltd. Internet Software/ServicesTechnology Services Tekiu Ltd. operates internet blogs that focus on trance and progressive house music. The British company was founded by Ted Ingemar Jakob Fjällman. | Founder | 12-03-2012 |
Synerkine Pharma BV
Synerkine Pharma BV Miscellaneous Commercial ServicesCommercial Services Synerkine Pharma BV focuses on developing novel fusion proteins for the treatment of inflammatory, neuropathic and osteoarthritic pain. The company was founded by Hans Preusting in 2018 and is headquartered in Utrecht, Netherlands. | Director/Board Member | 01-12-2021 |
Alder Therapeutics AB
Alder Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Alder Therapeutics AB is a cell therapy platform company that aims to develop and manufacture functional cell therapy products based on simple and robust processes. The company is based in Solna, Sweden. The Swedish company's unique platform allows for the manufacturing of better cells at a lower cost, making pluripotent cell therapy treatment available to more patients. The CEO of the company is Kristian Tryggvason. | Director/Board Member | 01-10-2022 |
Vitara Biomedical, Inc.
Vitara Biomedical, Inc. Packaged SoftwareTechnology Services Vitara Biomedical, Inc. engages in the biotechnology business. The company is headquartered in Philadelphia, PA. | Director/Board Member | 01-07-2022 |
Amarna Therapeutics BV
Amarna Therapeutics BV Medical/Nursing ServicesHealth Services Amarna Therapeutics BV operates as a biotechnology company developing SVac viral gene delivery vector platform. The firm has developed a proprietary SuperVero cell line and SVec gene delivery platform for the development of safe and efficient immunotherapies for major indications within the degenerative, inflammatory and autoimmune disease areas. The company was founded by Ben van Leent and Peter de Haan in 2008 and is headquartered in Leiden, the Netherlands. | Director/Board Member | 16-10-2019 |
NorthX Biologics Matfors AB
NorthX Biologics Matfors AB BiotechnologyHealth Technology NorthX Biologics Matfors AB is a biologics company that specializes in high-quality protein production and DNA manufacturing. The company is based in Matfors, Sweden, and has subsidiaries in Sweden. The Swedish company offers comprehensive cell banking services, including master cell bank production, GMP cell banking, and cell bank characterization, ensuring quality and compliance for biological products. The company also provides premium plasmid DNA services, offering GMP, High Quality, and Research Grade plasmids for gene therapy, cell therapy, molecular biology research, and clinical applications. The company was founded in 1963, and Janet Hoogstraate has been the CEO of the company since 2023. | Director/Board Member | 20-09-2022 |
CellProtect Nordic Pharmaceuticals AB
CellProtect Nordic Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Part of XNK Therapeutics AB, CellProtect Nordic Pharmaceuticals AB is a clinical-stage biotechnology company based in Huddinge, SE. CellProtect Nordic Pharmaceuticals is one of the pioneering companies in the field of cell therapy, developing unique and individualized natural killer (NK) cell-based cancer therapies. The Swedish company has built a tailor-made GMP clean room facility for manufacturing clinical products and is currently evaluating its lead product, evencaleucel, in a randomized, controlled, phase II study for the treatment of multiple myeloma. The private company was founded in 2012 and the CEO is Johan Liwing. | Director/Board Member | - |
░░░░░░ ░░░░░░ ░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Eerdere bekende functies van Ted Ingemar Jakob Fjällman
Bedrijven | Functie | Einde |
---|---|---|
░░░░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░ ░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░ ░░░░░░░░ ░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░ ░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Ted Ingemar Jakob Fjällman
University of Guelph | Doctorate Degree |
Waikato University | Undergraduate Degree |
University of Gothenburg | Graduate Degree |
International Space University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
MENDUS AB | Health Technology |
Bedrijven in privébezit | 18 |
---|---|
AgResearch Ltd.
AgResearch Ltd. Miscellaneous Commercial ServicesCommercial Services AgResearch Ltd. engages in research and development activities in the pastoral sector. It offers NaturOTM analgesia system, CARLA Saliva Test, WormFEC and MicroManual products. Its services include bioinformatics, development engineering, farms and deoxyribonucleic acid testing laboratory. The company was founded in 1992 and is headquartered in Hamilton, New Zealand. | Commercial Services |
Royal Swedish Academy of Engineering Sciences
Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Commercial Services |
The Bioindustry Association
The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Commercial Services |
Beactica Therapeutics AB
Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Distribution Services |
Sahlgrenska Universitetssjukhuset
Sahlgrenska Universitetssjukhuset Hospital/Nursing ManagementHealth Services Sahlgrenska Universitetssjukhuset engages in the provision of basic and emergency medical care. It offers specialized care, pediatrics, transplant activity, treatment of cardiovascular diseases, immunology, and vaccine research. Its hospital provides an infrastructure necessary for teaching and research. The company was founded on January 1, 1997 and is based in Gothenburg, Sweden. | Health Services |
CellProtect Nordic Pharmaceuticals AB
CellProtect Nordic Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Part of XNK Therapeutics AB, CellProtect Nordic Pharmaceuticals AB is a clinical-stage biotechnology company based in Huddinge, SE. CellProtect Nordic Pharmaceuticals is one of the pioneering companies in the field of cell therapy, developing unique and individualized natural killer (NK) cell-based cancer therapies. The Swedish company has built a tailor-made GMP clean room facility for manufacturing clinical products and is currently evaluating its lead product, evencaleucel, in a randomized, controlled, phase II study for the treatment of multiple myeloma. The private company was founded in 2012 and the CEO is Johan Liwing. | Health Technology |
Flerie Invest AB
Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | Finance |
Prokarium Ltd.
Prokarium Ltd. Miscellaneous Commercial ServicesCommercial Services Prokarium Ltd. operates as a biopharmaceutical company that focuses on developing vaccination solutions based on synthetic biology. Its oral vaccine delivery platform Vaxonella stimulates broad protective immune responses applicable to a wide range of diseases. The company is headquartered in Keele, the United Kingdom. | Commercial Services |
UK Research & Innovation
UK Research & Innovation BiotechnologyHealth Technology UK Research & Innovation is a partnership organization that works with universities, research organizations, businesses, charities, and government to create an environment that fosters research and innovation. The private company is based in London, UK. The organization aims to maximize the contribution of each component part, working both individually and collectively. UKRI collaborates with many partners to benefit everyone through knowledge, talent, and ideas. | Health Technology |
Geneos Therapeutics, Inc.
Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | Health Technology |
Amarna Therapeutics BV
Amarna Therapeutics BV Medical/Nursing ServicesHealth Services Amarna Therapeutics BV operates as a biotechnology company developing SVac viral gene delivery vector platform. The firm has developed a proprietary SuperVero cell line and SVec gene delivery platform for the development of safe and efficient immunotherapies for major indications within the degenerative, inflammatory and autoimmune disease areas. The company was founded by Ben van Leent and Peter de Haan in 2008 and is headquartered in Leiden, the Netherlands. | Health Services |
Synerkine Pharma BV
Synerkine Pharma BV Miscellaneous Commercial ServicesCommercial Services Synerkine Pharma BV focuses on developing novel fusion proteins for the treatment of inflammatory, neuropathic and osteoarthritic pain. The company was founded by Hans Preusting in 2018 and is headquartered in Utrecht, Netherlands. | Commercial Services |
Prokarium Holdings Ltd.
Prokarium Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Prokarium Holdings Ltd. provides management services. The private company is based in London, UK. The British company was founded in 2014. Kristen Albright has been the CEO of the company since 2018. | Commercial Services |
Tekiu Ltd.
Tekiu Ltd. Internet Software/ServicesTechnology Services Tekiu Ltd. operates internet blogs that focus on trance and progressive house music. The British company was founded by Ted Ingemar Jakob Fjällman. | Technology Services |
XNK Therapeutics AB
XNK Therapeutics AB Pharmaceuticals: MajorHealth Technology XNK Therapeutics AB operates as a technology platform which leads research on NK cells at Karolinska Institutet in Stockholm. The company was founded in 2012 and is headquartered in Huddinge, Sweden. | Health Technology |
Vitara Biomedical, Inc.
Vitara Biomedical, Inc. Packaged SoftwareTechnology Services Vitara Biomedical, Inc. engages in the biotechnology business. The company is headquartered in Philadelphia, PA. | Technology Services |
NorthX Biologics Matfors AB
NorthX Biologics Matfors AB BiotechnologyHealth Technology NorthX Biologics Matfors AB is a biologics company that specializes in high-quality protein production and DNA manufacturing. The company is based in Matfors, Sweden, and has subsidiaries in Sweden. The Swedish company offers comprehensive cell banking services, including master cell bank production, GMP cell banking, and cell bank characterization, ensuring quality and compliance for biological products. The company also provides premium plasmid DNA services, offering GMP, High Quality, and Research Grade plasmids for gene therapy, cell therapy, molecular biology research, and clinical applications. The company was founded in 1963, and Janet Hoogstraate has been the CEO of the company since 2023. | Health Technology |
Alder Therapeutics AB
Alder Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Alder Therapeutics AB is a cell therapy platform company that aims to develop and manufacture functional cell therapy products based on simple and robust processes. The company is based in Solna, Sweden. The Swedish company's unique platform allows for the manufacturing of better cells at a lower cost, making pluripotent cell therapy treatment available to more patients. The CEO of the company is Kristian Tryggvason. | Commercial Services |